IPCA LABORATORIES
Back to Balance Sheet
|
IPCA LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹11,744 Cr | ₹11,097 Cr | ₹8,623 Cr | ₹7,622 Cr | ₹6,066 Cr |
What is the latest Total Liabilities ratio of IPCA LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹11,744 Cr |
| Mar2024 | ₹11,097 Cr |
| Mar2023 | ₹8,623 Cr |
| Mar2022 | ₹7,622 Cr |
| Mar2021 | ₹6,066 Cr |
How is Total Liabilities of IPCA LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹11,744 Cr | 5.83 | |
| Mar2024 | ₹11,097 Cr | 28.69 | |
| Mar2023 | ₹8,623 Cr | 13.14 | |
| Mar2022 | ₹7,622 Cr | 25.63 | |
| Mar2021 | ₹6,066 Cr | - | |
Compare Total Liabilities of peers of IPCA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IPCA LABORATORIES | ₹43,186.1 Cr | 4.9% | 12.5% | 23% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,924.0 Cr | -0.3% | 3.4% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,619.0 Cr | -2.5% | -1.2% | -1.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹156,450.0 Cr | 2.4% | 5.2% | 47.2% | Stock Analytics | |
| CIPLA | ₹118,361.0 Cr | 2.2% | 4.8% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,253.0 Cr | 4.3% | 4.1% | 4.5% | Stock Analytics | |
IPCA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IPCA LABORATORIES | 4.9% |
12.5% |
23% |
| SENSEX | -0.8% |
0.8% |
-7.2% |
You may also like the below Video Courses